SCHEMBL7030829

SCHEMBL7030829

CC(C)COC(=O)N[C@@H](CNC(=O)c1ccc(OCCNC(=O)NCc2cccnc2)cc1O)C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 2/20 0.51
ALDH1A1 P00352 2/20 0.42
MAPT P10636 1/20 0.42
HTT P42858 1/20 0.42
GPR132 Q9UNW8 7/20 0.41
ITGB3 P05106 2/20 0.40
ITGAV P06756 2/20 0.40
ITGA2B P08514 1/20 0.40
TSHR P16473 1/20 0.40
FES P07332 1/20 0.39
RET P07949 1/20 0.39
MARK3 P27448 1/20 0.39
TYK2 P29597 1/20 0.39
FLT4 P35916 1/20 0.39
SYK P43405 1/20 0.39
CLK2 P49760 1/20 0.39
CLK4 Q9HAZ1 1/20 0.39
IDH1 O75874 1/20 0.39
POLB P06746 2/20 0.39
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7035562 0.93 NAMPT (0.53) NAMPTALDH1A1GPR132TSHRFES
SCHEMBL7035254 0.92 NAMPT (0.52) NAMPTALDH1A1MAPTGPR132ITGB3
SCHEMBL7033889 0.92 NAMPT (0.56) NAMPTGPR132ITGB3ITGAVITGA2B
SCHEMBL7036085 0.92 NAMPT (0.55) NAMPTALDH1A1GPR132TSHRFES
SCHEMBL7029576 0.92 ITGB3 (0.44) NAMPTMAPTITGB3ITGAVITGA2B
SCHEMBL7030493 0.91 NAMPT (0.51) NAMPTALDH1A1MAPTGPR132ITGB3
SCHEMBL7034102 0.91 NAMPT (0.53) NAMPTGPR132TSHRFESRET
SCHEMBL7032833 0.91 ITGB3 (0.39) NAMPTITGB3ITGAVITGA2BIDH1
SCHEMBL7032513 0.91 NAMPT (0.51) NAMPTGPR132ITGB3ITGAVITGA2B
SCHEMBL7036684 0.90 NAMPT (0.50) NAMPTGPR132ITGB3ITGAVTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030186967-A1 Acylresorcinol derivatives are selective vitronectin receptor inhibitors AMERICAN HOME PRODUCTS CORPORATION (US) 2003-10-02 US claimed
WO-1999052879-A1 ACYLRESORCINOL DERIVATIVES AS SELECTIVE VITRONECTIN RECEPTOR INHIBITORS AMERICAN HOME PRODUCTS CORPORATION (US) 1999-10-21 WO claimed
US-20030186967-A1 Acylresorcinol derivatives are selective vitronectin receptor inhibitors AMERICAN HOME PRODUCTS CORPORATION (US) 2003-10-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030186967-A1 Acylresorcinol derivatives are selective vitronectin receptor inhibitors ASGR1, TEK, APLNR NAMPT 566/4885ALDH1A1 2356/4885MAPT 4566/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.